Decreased IgE Activity
- Name
- Decreased IgE Activity
- Accession Number
- DBCAT004419
- Description
Not Available
- Drugs
Drug Drug Description Omalizumab A monoclonal anti-immunoglobulin E (IgE) antibody used to treat asthma, chronic idiopathic urticaria, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergy. - Drugs & Drug Targets
Drug Target Type Omalizumab High affinity immunoglobulin epsilon receptor subunit alpha target Omalizumab High affinity immunoglobulin epsilon receptor subunit beta target